Thank you NR for breaking it down and confirming my analysis. When it comes to B we are looking at a Micheal Jordan slam dunk from the Free Throw line... Graceful and assured.

GO B and GO CTIX!

Thank you BK, your timing is priceless.

GO CTIX and GO B Defensin Mimetics!!!!

I sure hope so, but when it comes to all things related to K ASCO makes a better venue... you just never know.

GO CTIX!!!

Minotaur, B has had the spotlight lately and it has deserved it because it has de-risked CTIX going forward and will save countless lives so Im very thankful for B, but I have also felt that K has fallen off the public radar this past year but I have a great deal of faith in Dr. Menon and understand that we jut have to wait BUT IT SHOULD BE WORTH THE WAIT.

Go CTIX and Pt. X!!!

I don't have anything to offer but thats what brought me here and what keeps me excited.

We should have started the U of Bologna study by now, we should be receiving SPORE grant results by now and we should get updates for the latest cohort progression and any other agreements with universities out there.

***Lastly, Leo and Dr. Menon plan EVERYTHING out in great detail and have let us know that they expect MTD around this dosage so I also expect news of this any day now BUT Im very optimistic in that as long as there is some benefit to the patients that they will continue to receive treatment with K and that alone is reason for fireworks!

GO Patient X!!!!

I want to hear about PT "X" and the SPORE Grant and everything else will just be honey on my biscuit.


GO CTIX!!!

Thanks for sharing this link. I love the greater visibility.

GO CTIX!!!

I think you are on to something there BUT there is no holds barred on releasing data on any other compound.

Go CTIX!!!

I stopped reading that trash years ago and i suggest people do their DD and not depend on spinster turds.

GO CTIX!!!

Cheers to all! Wishing everyone a prosperous and happy new year!

GO CTIX!!!!

My bet is we got the spore grant for K against renal Cancer un combination with S (don't recall the spelling).


Remember, it was the first time ever that the researchers witnessed tumor shrinkage!!!!

GO CTIX!!!

The IRB greenlight for B-OM is what I really found to be the most exciting! Soon it will be listed on clinical trials.gov!

IRB have green light on B-OM! We now have another phase II clinical trial folks and this trial is will get us additional exposure and to market the fastest!

GO CTIX!!!

A watched pot never boils.

GO CTIX!!!

Many bailed out after polyheist... You know how that story ends.

GO CTIX!!!!

They are not exiting in waves. In my opinion 100 shares at a time is obvious tree shaking. Good bye!

GO CTIX!!!

Thats the drum that I've been beating! The closer we go to 30 days without a PR the more excited I become! In fact I kind of want momentous to hurry along so I can reset my calandar! I want a DEAL!!!!

GO CTIX!!!

John, Im thinking thats exactly what the shelf was intended for. Leo is going to perform the old "rope a dope" on skeptics!

Also as I mentioned before, results from that spore grant application for studying K with S in-combo against renal cancer is long overdue!!! It was the first time researchers ever witnessed shrinkage!!! Its possible the shrinkage had nothing to do with S and K steals the show.

Ok, Im getting too excited and will stop but you cant stop CTIX!!!

What the P53??? No way!!!

So what are we considering a "whale" at these prices??? 100k blocks???

I think we will finally find out what that 65lb gorilla was all about!!!!


Go CITIX and krismakwanzkha (momentous) and B!!!

Very thorough! impressive! Thank you for sharing the knowledge! I'm no where near reading everything bet felt that you should be thanked!

GO CTIX and GO P!!!

100 Trillion dollars (or euros) should cause quite a panic in the UK and facilitate European approval of B with arms wide open!!!


GO CTIX and worldwide fear of superbugs!!!

Holy P53 TOB!!! Thanks!!!


***are we allowed to cuss here???

GO CTIX!!! P53 the rest!

Pigs get slaughtered. If the Cubist deal falls apart and they only receive the $250 mill Cubist will be in big trouble in a few years when generics hit and then B could bring an end to their whole enchilada when it hits market.

GO CTIX!!!

Daydream, there are many newcomers and they are just starting their due diligence and good due diligence takes a while and shouldn't be rushed so I think it may be a few days more before the value of P in the CTIX equation is even factored in. I think we are still just riding the QIDP announcement.

GO CTIX! GO B and P and K and Patient X!!!

Love is in the air! GO CTIX!!!

I apologize in advance if this was already posted but we (B) made it on CNN money!

http://money.cnn.com/news/newsfeeds/articles/marketwire/1163498.htm

What a joke!

Well said BooDog! GO CTIX and GO SNOOPY DANCE!!!

Hound, this is what new investors need to understand, Leo and Dr.M do not play! They don't just sit around typing fluffy PRs, they are actually working hard behind the scenes and are building a legacy. This stock has been diversified by their actions in developing the multiple compounds and as a result presents an opportunity to invest in a "quasi fund" of sorts under one stock symbol. The recent 3rd party endorsement by the FDA should keep all those looking to discredit CTIX some pause.


GO CTIX!!!

Hound, this is what new investors need to understand, Leo and Dr.M do not play! They don't just sit around typing fluffy PRs, they are actually working hard behind the scenes and are building a legacy. This stock has been diversified by their actions in developing the multiple compounds and as a result presents an opportunity to invest in a "quasi fund" of sorts under one stock symbol. The recent 3rd party endorsement by the FDA should keep all those looking to discredit CTIX some pause.


GO CTIX!!!

***This is what I believe has fallen off the radar for most and what would truly be "Momentous"!

We have not heard anything more about the combination of K and S and the prestigious Spore grant! If we did in fact receive it and they are just waiting on safety outcomes before starting, we could be blessed with an announcement this month indicating a new combo trial for K! Remember that this was the first time that renal cell cancer showed shrinkage!

GO CTIX!!!!

BEVERLY, MA – January 24, 2013– Cellceutix Corporation (OTCBB: CTIX) (the “Company”), a clinical stage biopharmaceutical company focused on discovering small molecule drugs to treat unmet medical conditions, including drug-resistant cancers and autoimmune diseases, announces today that the Company has received results from in vivo studies conducted at Beth Israel Deaconess Medical Center (“BIDMC”). Cellceutix had earlier reported that they entered into an agreement with BIDMC, a teaching hospital of Harvard Medical School, on an innovative research project with Kevetrin™, the Company’s flagship anti-cancer drug. BIDMC wishes to exploit the nuclear and/or mitochondrial pro-apoptotic function of p53 in melanoma and renal cell carcinoma, two types of cancer that are particularly resistant to therapy.

Research by BIDMC combined Kevetrin™ with sunitinib on cell line 786, a drug-resistant renal cancer. Cellceutix was advised by the researchers that “the Kevetrin/sunitinib combination is the first we’ve used in which actual tumor shrinkage is noted.”

Per protocol, Cellceutix has formally notified BIDMC that it has a strong interest in further collaborative efforts to develop combination treatments with Kevetrin and multikinase VEGF receptor antagonists, particularly VEGFR2 inhibitors. Cellceutix has provided the requested information that will be used to investigate a Specialized Programs of Research Excellence (SPORE) grant for a phase 2 clinical study.

Renal cell carcinoma is the most common type of kidney cancer in adults. BIDMC is the lead recipient of the prestigious National Cancer Institute-funded kidney cancer SPORE grant.

About SPORE
In 1992, the National Cancer Institute (NCI) established the Specialized Programs of Research Excellence (SPOREs), specialized cancer center grants to promote and speed up the exchange between interdisciplinary research in the laboratory to the treatment of patients in the clinical care setting.

SPORE programs allow laboratory and clinical scientists to work collaboratively to plan, design, and implement research programs with the greatest potential to impact cancer prevention, detection, diagnosis and treatment.

- See more at: http://cellceutix.com/cellceutix-reports-in-vivo-tumor-shrinkage-in-renal-cancer/#sthash.riX9Ni3P.dpuf

Now that's great publicity and more is sure to follow! Thanks for posting!

GO CTIX!!!

The author is clueless. He doesn't have B anywhere on his radar. We are going to take the industry by storm!

GO CTIX!!!!

CTIX not doing so bad for a Pinkie

GO CTIX!!!!

QDIP+ Dr. Reddys + B 65lb Gorilla= Revenue in 2016!!!!!


GO CTIX!!!!

The answer to your question is "paints"!

Last time i was in Hong Kong we would say we drank pints of Guiness and would drink till we got painted which evolved into drinking "paints"! So we drank pints till we got painted therefore plural is not in brand but size... "Paints"!

Go Guni! Go Ctix! And Go Patient X!

How about 2 guiness! Stay a while. Go CTIX!!!